RESEARCH PAPER
Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
 
More details
Hide details
1
Collaborative Orthopaedic Research (CORe), Department of Physical Therapy, University of Alberta, Edmonton, Canada
2
Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Canada
3
Collaborative Orthopaedic Research (CORe), Department of Surgery, University of Alberta, Edmonton, Canada
CORRESPONDING AUTHOR
Lauren A. Beaupre   

Collaborative Orthopaedic Research (CORe), Department of Physical Therapy, 6-110 Clinical Sciences Building, University of Alberta, Edmonton, Alberta T6G 2G3, Canada
Publish date: 2019-02-22
 
Tob. Induc. Dis. 2019;17(February):14
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation program compared to usual care for patients undergoing TJR. Secondarily, we evaluated the use of the smoking cessation program.

Methods:
A pre-post quasi-experimental study was conducted at a central intake clinic that prepares approximately 3000 TJR patients annually. Participants were recruited at a mean of 13±11.1 weeks preoperatively and provided informed consent. Participants in the ‘pre’ observational phase (OP) received usual care for smoking cessation. For ‘post’ intervention phase (IP) participants, a referral was sent to a community-based pharmacist-led smoking cessation program. Smoking status was validated on study entry using exhaled carbon monoxide. Participants’ smoking status was re-assessed using self-reported point prevalence abstinence at 6 months post-recruitment.

Results:
We enrolled 120/150 (80%) potential OP candidates and 104/286 (36%) potential IP candidates. The groups were similar on study entry; overall, the mean age of participants was 58.7±9.1 years and 103 (47%) were male. They reported medium nicotine dependence with 37±11.6 mean years smoked. At 6 months post-recruitment, 8 (7%) OP participants self-reported 30-day point prevalence abstinence compared to 21 (20%) IP participants (p=0.003). Only 58 (56%) IP participants complied with the pharmacist referral, with 19 (33%) of those seeing the pharmacist reporting point prevalence abstinence at 6 months compared to only 2 (4%) of the 45 participants who did not see the pharmacist (p<0.001).

Conclusions:
Referral to a community smoking cessation program as preoperative standard of care is feasible and can enhance long-term quit rates, but voluntary participation led to low recruitment to the program.

CONFLICTS OF INTEREST
The authors declare that they have no competing interests, financial or otherwise, related to the current work. BA Finegan reports grants from Pfizer, during the conduct of the study and personal fees from Pfizer, outside the submitted work. The rest of the authors have also completed and submitted an ICMJE form for disclosure of potential conflicts of interest.
 
REFERENCES (30)
1. Singh JA. Smoking and outcomes after knee and hip arthroplasty: a systematic review. J Rheumatol. 2011;38(9):1824-1834. doi:10.3899/jrheum.101221
2. Sahota S, Lovecchio F, Harold RE, Beal MD, Manning DW. The Effect of Smoking on Thirty-Day Postoperative Complications After Total Joint Arthroplasty: A Propensity Score-Matched Analysis. J Arthroplasty. 2018;33(1):30-35. doi:10.1016/j.arth.2017.07.037
3. Lilley M, Krosin M, Lynch TL, Leasure J. Orthopedic Surgeons' Management of Elective Surgery for Patients Who Use Nicotine. Orthopedics. 2017;40(1):e90-e94. doi:10.3928/01477447-20160901-02
4. Jimenez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46(1):61-79. doi:10.1183/09031936.00092614
5. Joly B, D'Athis P, Gerbaud L, Hazart J, Perriot J, Quantin C. Smoking cessation attempts: is it useful to treat hard core smokers? Tob Induc Dis. 2016;14(November). doi:10.1186/s12971-016-0100-0
6. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008;35(2):158-176. doi:10.1016/j.amepre.2008.04.009
7. Health Canada. Canadian Tobacco Alcohol and Drugs Survey (CTADS): 2015 Summary. https://www.canada.ca/en/healt.... Accessed January 5, 2018.
8. Argintar E, Triantafillou K, Delahay J, Wiesel B. The musculoskeletal effects of perioperative smoking. J Am Acad Orthop Surg. 2012;20(6):359-363. doi:10.5435/jaaos-20-06-359
9. Wright E, Tzeng TH, Ginnetti M, et al. Effect of Smoking on Joint Replacement Outcomes: Opportunities for Improvement Through Preoperative Smoking Cessation. Instruct Course Lec. 2016;65:509-520.
10. Sachs R, Wild TC, Thomas L, Hammal F, Finegan BA. Smoking cessation interventions in the pre-admission clinic: Assessing two approaches. Can J Anesthes. 2012;59(7):662-669. doi:10.1007/s12630-012-9716-6
11. Saxony J, Cowling L, Catchpole L, Walker N. Evaluation of a smoking cessation service in elective surgery. J Surg Res. 2017;212:33-41. doi:10.1016/j.jss.2016.11.056
12. Taylor H, Karahalios A, Bramley D. Long-term effectiveness of the preoperative smoking cessation programme at Western Health. ANZ J Surg. 2017;87(9):677-681. doi:10.1111/ans.14113
13. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159. doi:10.1080/14622200210123581
14. Alberta Pharmacists' Association. QUIT (Quit Using and Inhaling Tobacco) Smoking Cessation Program. https://rxa.ca/professional-de.... Accessed October 13, 2017.
15. Canadian Pharmacists Association. Pharmacists' Expanded Scope of Practice in Canada. https://www.pharmacists.ca/cph.... Published, 2015. Accessed January 5, 2016.
16. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services; 2008. http://www.ncbi.nlm.nih.gov/bo.... Accessed August 28, 2018.
17. Pierre S, Rivera C, Le Maître B, et al. Guidelines on smoking management during the perioperative period. Anaesthes Crit Care Pain Med. 2017;36(3):195-200. doi:10.1016/j.accpm.2017.02.002
18. Wong J, Abrishami A, Riazi S, et al. A Perioperative Smoking Cessation Intervention with Varenicline, Counseling, and Fax Referral to a Telephone Quitline Versus a Brief Intervention: A Randomized Controlled Trial. Anesthesia & Analgesia. 2017;125(2):571-579. doi:10.1213/ane.0000000000001894
19. Saba M, Diep J, Saini B, Dhippayom T. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Therapeut. 2014;39(3):240-247. doi:10.1111/jcpt.12131
20. Chapman S, Freeman B. Markers of the denormalisation of smoking and the tobacco industry. Tob Control. 2008;17(1):25-31. doi:10.1136/tc.2007.021386
21. Johnson SE, Coleman B, Tessman GK, Dickinson DM. Unpacking smokers' beliefs about addiction and nicotine: A qualitative study. Psychol Addict Behav. 2017;31(7):744-750. doi:10.1037/adb0000321
22. Nahhas GJ, Wilson D, Talbot V, et al. Feasibility of Implementing a Hospital-Based "Opt-Out" Tobacco-Cessation Service. Nicotine Tob Res. 2017;19(8):937-943. doi:10.1093/ntr/ntw312
23. Kulkarni K, Karssiens SJ, Massie H, Pandit H. Smoking and orthopaedic surgery: Does the evidence support rationing of care? Musculoskeletal Care. 2017;15(4):400-404. doi:10.1002/msc.1180
24. Lampley A, Huang RC, Arnold WV, Parvizi J. Total joint arthroplasty: should patients have preoperative dental clearance? J Arthroplasty. 2014;29(6):1087-1090. doi:10.1016/j.arth.2013.11.019
25. Tokarski AT, Patel RG, Parvizi J, Deirmengian GK. Dental clearance prior to elective arthroplasty may not be needed for everyone. J Arthroplasty. 2014;29(9):1729-1732. doi:10.1016/j.arth.2014.04.018
26. Aggarwal VK, Tischler EH, Lautenbach C, et al. Mitigation and education. J Orthop Res. 2014;32:S16-S25. doi:10.1002/jor.22547
27. Soulakova JN, Hartman AM, Liu B, Willis GB, Augustine S. Reliability of adult self-reported smoking history: data from the tobacco use supplement to the current population survey 2002-2003 cohort. Nicotine Tob Res. 2012;14(8):952-960. doi:10.1093/ntr/ntr313
28. Frei M, Engel BO, Sendi P, Reichart PA, Ramseier CA, Bornstein MM. Assessment of smoking behaviour in the dental setting. A study comparing self-reported questionnaire data and exhaled carbon monoxide levels. Clin Oral Investig. 2012;16(3):755-760. doi:10.1007/s00784-011-0583-2
29. Song F, Brown TJ, Blyth A, Maskrey V, McNamara I, Donell S. Identifying and recruiting smokers for preoperative smoking cessation-a systematic review of methods reported in published studies. Systematic Reviews. 2015;4:157. doi:10.1186/s13643-015-0152-x
30. Wong J, Lam DP, Abrishami A, Chan MTV, Chung F. Short-term preoperative smoking cessation and postoperative complications: A systematic review and meta-analysis. Can J Anesthes. 2012;59(3):268-279. doi:10.1007/s12630-011-9652-x
eISSN:1617-9625